A combination treatment approach using two chemotherapy drugs improved treatment response and progression-free survival in patients with advanced pancreatic neuroendocrine tumors, according to a recent clinical trial published ...
Apr 13, 2023
0
4
Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, ...
Apr 4, 2023
0
31
A newly published study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation.
Mar 30, 2023
0
16
When older adults with cancer take multiple medications—including ordinary drugs like blood pressure pills, supplements, or antacids—it can result in more toxic chemotherapy side effects and even a need to stop cancer ...
Feb 27, 2023
0
3
A recent study published in Nature Communications has identified novel genetic causes of non-obstructive azoospermia (NOA), the most severe form of male infertility, findings that improve the characterization of the disorder ...
Feb 13, 2023
0
22
Engineers at the University of Waterloo have developed artificial intelligence (AI) technology to predict if women with breast cancer would benefit from chemotherapy prior to surgery.
Feb 7, 2023
0
29
Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to the results of a Cancer Research UK clinical trial.
Jan 19, 2023
0
6
A new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international multicenter trial involving researchers at UCL and University College London Hospitals ...
Jan 18, 2023
0
42
High doses of vitamin D alleviated symptoms for patients with toxic erythema of chemotherapy (TEC) significantly faster than current treatments, according to a Northwestern Medicine study published in JAMA Dermatology.
Jan 18, 2023
0
127
Late-breaking research reveals a major treatment advance for adults with newly diagnosed B lineage acute lymphoblastic leukemia (ALL). The randomized phase 3 study E1910 evaluated blinatumomab immunotherapy in patients with ...
Dec 13, 2022
0
3
